ALS2CL


Summary:

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location
OMIM IDMIM:612402
PHARMGKB IDPA134949717
Map Location3p21.31

GO terms in ALS2CL


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
BP IGI GO:0007032 endosome organization
BP IEA GO:0043547 positive regulation of GTPase activity
CC TAS GO:0005829 cytosol
MF IEA GO:0005096 GTPase activator activity
MF TAS GO:0017112 Rab guanyl-nucleotide exchange factor activity
MF IPI GO:0042802 identical protein binding
Showing 1 to 6 of 6 rows

Gene expression in normal tissue: ALS2CL

Gene-model tissue-cancer distribution: Bubble Plot

undefinetissue: undefine cancer: undefined model num: 0undefinedtissue: undefined cancer: PANCAN model num: 6BREAStissue: BREAS cancer: BREAST model num: 0BREASTtissue: BREAST cancer: Breast Carcinoma model num: 1

Gene-drug pathway distribution

VEGF signaling pathway1RTK signaling1ERK MAPK signaling1EGFR signaling1

Pathways in ALS2CL


Loading, please wait...
Database
Pathway ID
Pathway Des.
reactome R-HSA-199991 Membrane Trafficking
reactome R-HSA-5653656 Vesicle-mediated transport
reactome R-HSA-8876198 RAB GEFs exchange GTP for GDP on RABs
reactome R-HSA-9007101 Rab regulation of trafficking
Showing 1 to 4 of 4 rows

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD131 Erlotinib 1
iGMDRD353 PD0325901 1
iGMDRD409 Saracatinib 3
iGMDRD134 Sorafenib 2
Showing 1 to 4 of 4 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in ALS2CL

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​